April 2 (Reuters) - U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S.

Jared Holz, Mizuho, joins 'Fast Money' to talk what's ahead for pharmaceutical companies in the obesity drug market.

By Marleen Kaesebier ZURICH, April 3 (Reuters) - U.S. President Donald Trump's 100% tariffs on the pharmaceutical industry ...

New US pharmaceutical tariffs reach up to 100%, with exemptions for companies that strike pricing deals or commit to domestic manufacturing.

The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to ...

Explore how life-science companies adapt office spaces to balance hybrid work flexibility with the need for innovation, ...

Amcor, Aptar Group, CCL Industries, Gerresheimer AG, Schott AG, SGD Pharma, West Pharmaceutical Services — are examined.

Levan Gogiberidze stated that the mandatory introduction of Good Manufacturing Practice (GMP) standards in Georgia has ...

Administration will impose tariffs of as much as 100% on certain imported medicines to pressure drugmakers to manufacture ...

After a wave of high-profile pledges to bring pharmaceutical manufacturing back to the United States, a clearer picture of ...

President Trump has announced a new pharmaceutical tariff that would impose as much as 100% on imported brand-name drugs. The ...